ARX-622

N/A

Report date: 2024/05/27 17:13:27

Base Information

Drug NameARX-622
Drug Alias NameARX-622ARX622
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionToll like receptor 7 agonistsReceptor protein-tyrosine kinase erbB-2 modulators
TargetsToll like receptor 7Receptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAmbrx Inc
China Registration ClassN/A

Develop Information

Active CompaniesAmbrx Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A